» Articles » PMID: 26832931

Opioid Substitution Therapy: Lowering the Treatment Thresholds

Overview
Publisher Elsevier
Specialty Psychiatry
Date 2016 Feb 3
PMID 26832931
Citations 73
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Opioid substitution therapy (OST) has been established as the gold standard in treating opioid use disorders. Nevertheless, there is still a debate regarding the qualitative characteristics that define the optimal OST intervention, namely the treatment threshold. The aim of this review is twofold: first, to provide a summary and definition of "treatment thresholds", and second, to outline these thresholds and describe how they related to low and high threshold treatment characteristics and outcomes.

Method: We searched the main databases of Medline, PubMed, PsycInfo, EMBASE, CINAHL and the Cochrane Library. Original published research papers, reviews, and meta-analyses, containing the eligible keywords: "opioid substitution", "OST", "low threshold", "high threshold" were searched alone and in combination, up to June, 2015.

Results: Treatment thresholds were defined as barriers a patient may face prior to and during treatment. The variables of these barriers were classified into treatment accessibility barriers and treatment design barriers. There are increasing numbers of studies implementing low threshold designs with an increasing body of evidence suggesting better treatment outcomes compared to high threshold designs.

Conclusion: Clinical characteristics of low threshold treatments that were identified to increase the effectiveness of OST intervention include increasing accessibility so as to avoid waiting lists, using personalized treatment options regarding medication choice and dose titration, flexible treatment duration, a treatment design that focuses on maintenance and harm reduction with emphasis on the retention of low adherence patients.

Citing Articles

Patient-Reported Experience Measures for In- and Outpatients in Mental Health and Substance Use Services: Psychometric Properties and Results From a Nationwide Survey in Finland.

Viertio S, Therman S, Kuussaari K, Suvisaari J Int J Methods Psychiatr Res. 2024; 34(1):e70010.

PMID: 39729570 PMC: 11676435. DOI: 10.1002/mpr.70010.


"I still can feel the sickness": Withdrawal experiences of people on methadone maintenance treatment.

Frank D, Bennett A, Cleland C, Meyerson B, Russell D, Walters S J Subst Use Addict Treat. 2024; 170:209616.

PMID: 39722353 PMC: 11885047. DOI: 10.1016/j.josat.2024.209616.


[Intensive care and emergency medicine overuse and sustainability].

Kochanek M, Berek M, Janssens U, Kitz V, Wilkens F Med Klin Intensivmed Notfmed. 2024; 120(1):22-29.

PMID: 39653814 DOI: 10.1007/s00063-024-01224-x.


"Bupe by the Book": A study protocol for a pilot randomized controlled trial of library-facilitated telehealth to increase buprenorphine treatment among unstably housed individuals.

Urada L, Marienfeld C, Partch M, Garfein R, Strathdee S, Nicholls M Res Sq. 2024; .

PMID: 39649172 PMC: 11623763. DOI: 10.21203/rs.3.rs-5507141/v1.


Community-Based Medications First for Opioid Use Disorder - Care Utilization and Mortality Outcomes.

Banta-Green C, Owens M, Williams J, Floyd A, Williams-Gilbert W, Kingston S Subst Abuse Rehabil. 2024; 15:173-183.

PMID: 39295965 PMC: 11409926. DOI: 10.2147/SAR.S475807.